Processa Pharmaceuticals, Inc. Logo

Processa Pharmaceuticals, Inc.

Develops next-gen chemo and therapies for chronic and life-threatening diseases.

PCSA | US

Overview

Corporate Details

ISIN(s):
US74275C2052
LEI:
Country:
United States of America
Address:
601 21ST STREET, SUITE 300, 32960 VERO BEACH
Sector:
Manufacturing
Industry:
Manufacture of pharmaceuticals, medicinal chemical and botanical products

Description

Processa Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company focused on developing therapies for patients with unmet medical needs in life-threatening and chronic diseases. The company's core mission is to improve patient survival and quality of life by developing Next-Generation Chemotherapy (NGC) drugs that enhance the safety and efficacy of cancer treatments. Its development pipeline includes drug candidates such as PCS6422 for metastatic colorectal and breast cancer, PCS499 for Ulcerative Necrobiosis Lipoidica, and PCS12852 for gastroparesis. Processa utilizes a distinct regulatory science approach, leveraging its experienced leadership team's R&D and regulatory expertise to accelerate drug development and efficiently position products for successful approval.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
No filings match the current criteria.

Automate Your Workflow. Get a real-time feed of all Processa Pharmaceuticals, Inc. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for Processa Pharmaceuticals, Inc.

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for Processa Pharmaceuticals, Inc. via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Company Country Ticker View
BioLineRx Ltd. Logo
A biopharmaceutical firm developing and commercializing therapies for oncology and rare diseases.
United States of America BLRX
BIOMARIN PHARMACEUTICAL INC Logo
Develops and commercializes therapies for rare, life-threatening genetic diseases.
United States of America BMRN
BioMaxima S.A. Logo
Manufacturer of IVD solutions including tests, reagents, and equipment for medical labs.
Poland BMX
Biomea Fusion, Inc. Logo
Develops oral small molecules for metabolic diseases like diabetes and for specific cancers.
United States of America BMEA
BIOMERICA INC Logo
Develops diagnostic tests for GI, inflammatory diseases, and diabetes for lab and at-home use.
United States of America BMRA
bioMérieux Logo
Provides in vitro diagnostic solutions for clinical and industrial microbiology.
France BIM
BiomX Inc. Logo
Develops phage therapies to target harmful bacteria in chronic diseases like cystic fibrosis.
United States of America PHGE
BioNTech SE Logo
Pioneering mRNA immunotherapies and vaccines to combat cancer and infectious diseases.
United States of America BNTX
BioPorto Logo
IVD company developing NGAL biomarkers for early acute kidney injury (AKI) risk assessment.
Denmark BIOPOR
BioRestorative Therapies, Inc. Logo
A clinical-stage company developing stem cell therapies for pain, metabolic disorders, and aesthetics.
United States of America BRTX

Talk to a Data Expert

Have a question? We'll get back to you promptly.